The French oncology company MaaT Pharma SA has appointed Savita Bernal as chief business officer. Dr Bernal will develop the company’s commercial strategy to promote its microbiome-based therapies for cancer and other life-threatening diseases. An experienced business and marketing executive, Dr Bernal joins MaaT from ADOCIA SAS, where she was responsible for out-licensing deals and R&D collaborations. Dr Bernal has a master's degree from the HEC Paris Business School, and a PhD in cognitive neuroscience from the Université Pierre et Marie Curie, both in France.
MaaT Pharma announced this appointment on 28 May 202
Copyright 2020 Evernow Publishing Ltd